Donovanosis overview

Jump to navigation Jump to search

Donovanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Donovanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Donovanosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Donovanosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Donovanosis overview

CDC on Donovanosis overview

Donovanosis overview in the news

Blogs on Donovanosis overview

Directions to Hospitals Treating Donovanosis

Risk calculators and risk factors for Donovanosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Overview

Donovanosis is a sexually transmitted disease that has reached endemic proportions in many underdeveloped regions. Because of the scarcity of medical treatment, the disease often goes untreated. The disease is characterized by painless genital ulcers which can be mistaken for syphilis.[1] However, they ultimately progress to destruction of internal and external tissue, with leakage of mucus and blood. The destructive nature of donovanosis also increases the risk ofsuperinfection by other pathogenic microbes.

Historical Perspective

Donovanosis was first called "serpiginous ulcer" in 1882. Charles Donovan first identified the cause of these genital lesions in 1905, which he called "Donovan bodies," since the etiologic agent was unknown. Aragão & Vianna classified the agent as Calymmatobacterium granulomatis in 1913. However, sequencing analysis by Carter et al. revealed that the agent should be reclassified to Klebsiella granulomatis.

Pathophysiology

Causes

The causative organism, Klebsiella granulomatis, used to be called Calymmatobacterium granulomatis, from the Greek kalymma (a hood or veil), referring to the lesions that contain the bacteria. Prior to this it was called Donovania granulomatis, named after the Donovan Bodies.[2] The species name granulomatis refers to the granulomatous lesions. The organism was recently reclassified under the genus Klebsiella, a drastic taxonomic change, since it involved changing the organism's phylum.

Classification

Donovanosis may be classified by four different clinical appearances of the lesion: ulcerogrnulomatous, hypertrophic or verrucous, nectrotic, or sclerotic. Ulcerogrnulomatous is the most common.

Differential Diagnosis

Donovanosis must be differentiated from other diseases that cause genital ulcers without lymphadenopathy including: primary or secondary syphilis, chancroid, herpes simplex, amoebiasis, and squamous cell carcinoma. Sexually transmitted diseases characterized as genital ulcer diseases may present with similar manifestations and lesion characteristics.

Epidemiology and Demographics

A true incidence of donovanosis is difficult to determine due to limited knowledge of the disease, limited diagnostic tests, infrequency of disease compared to other sexually transmitted diseases, and occurrence of the disease in areas with limited resources. Most infections occur in people who's ages range from 20 to 40 years. Sex and race are not a predilection for acquiring the disease. Donovanosis is rare in the United States and other developed countries. Donovanosis is endemic in tropical and developing areas, including India, Papua New Guinea, the Caribbean, central Australia, and southern Africa.

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Clinically, the disease is commonly characterized as painless, progressive ulcerative lesions without regional lymphadenopathy.

Laboratory Findings

Treatment

Medical Therapy

Prevention

Avoiding all sexual activity is the only absolute way to prevent a sexually transmitted disease such as donovanosis. However, safer sex behaviors may reduce your risk.

The proper use of condoms, either the male or female type, greatly decreases the risk of catching a sexually transmitted disease. You need to wear the condom from the beginning to the end of each sexual activity.

References

  1. Murray P. et al. (2005), Medical Microbiology, fifth ed., Elsevier Mosby, p. 336.
  2. Murray P. et al. (2005), Medical Microbiology, fifth ed., Elsevier Mosby, p. 336.


Template:WikiDoc Sources